MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer

BACKGROUND: In the absence of targetable mutations or immune checkpoints, cisplatin-doublet chemotherapy remains the standard of care in non-small cell lung cancer (NSCLC). Drug resistance has however become a significant clinical challenge. Exploring a role for small non-coding microRNAs (miRNA) as...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Lung Cancer Res
Päätekijät: MacDonagh, Lauren, Gallagher, Michael F., Ffrench, Brendan, Gasch, Claudia, Gray, Steven G., Reidy, Marie, Nicholson, Siobhan, Leonard, Niamh, Ryan, Ronan, Young, Vincent, O’Leary, John J., Cuffe, Sinead, Finn, Stephen P., O’Byrne, Kenneth J., Barr, Martin P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107736/
https://ncbi.nlm.nih.gov/pubmed/34012792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-959
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia